Growth hormone deficiency

Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency
Fotocitizen / Pixabay

Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency

  Rare Community Profiles is a Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families, advocates, scientists, and more.…

Continue Reading Rare Community Profiles: Dr. Pisit “Duke” Pitukcheewanont Discusses Phase 2 Results in LUM-201 for Pediatric Growth Hormone Deficiency
ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency
source: unsplash.com

ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency

  The ENDO 2022 Annual Congress took place from June 11-14, 2022. During the Congress, stakeholders met to discuss care, treatments, and research within endocrinology. In a news release from…

Continue Reading ICYMI: Evaluating Sogroya for Pediatric Growth Hormone Deficiency
Phase 3 Childhood-Onset Growth Hormone Deficiency Trial Continues Enrollment
jarmoluk / Pixabay

Phase 3 Childhood-Onset Growth Hormone Deficiency Trial Continues Enrollment

Aeterna Zentaris’s ongoing DETECT trial is evaluating the drug macimorelin (tradename Macrilen™) for childhood-onset growth hormone deficiency (CGHD). As recently announced in an article published by GlobeNewsWire, the study (AEZS-130-PO2),…

Continue Reading Phase 3 Childhood-Onset Growth Hormone Deficiency Trial Continues Enrollment
Ways to Support Those with Pediatric Growth Hormone Deficiency
source: pixabay.com

Ways to Support Those with Pediatric Growth Hormone Deficiency

Growth hormone deficiency (GHD) influences patients both physically and mentally. The condition means patients' bodies don't produce enough growth hormone. As a result, they don't develop the same way as…

Continue Reading Ways to Support Those with Pediatric Growth Hormone Deficiency
An Experimental Treatment for Growth Hormone Deficiency Performs Well in Phase 3 Trial
Free-Photos / Pixabay

An Experimental Treatment for Growth Hormone Deficiency Performs Well in Phase 3 Trial

According to a story from globenewswire.com, the experimental drug somatrogon, which is being co-developed by Pfizer, Inc. and OPKO Health, Inc., was able to achieve its primary endpoint in a…

Continue Reading An Experimental Treatment for Growth Hormone Deficiency Performs Well in Phase 3 Trial
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Policy
Privacy Policy for CA Residents
EU Privacy Notice
Privacy Shield Policy

Facebook Twitter Tiktok Instagram Linkedin

© Copyright Patient Worthy